STRN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.378000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.633400E-01
Normal-vs-Stage2
8.027200E-01
Normal-vs-Stage3
2.882800E-03
Normal-vs-Stage4
9.368400E-01
Stage1-vs-Stage2
5.954000E-01
Stage1-vs-Stage3
1.755530E-02
Stage1-vs-Stage4
4.119000E-01
Stage2-vs-Stage3
2.208800E-04
Stage2-vs-Stage4
7.009600E-01
Stage3-vs-Stage4
7.325500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.128600E-01
Normal-vs-AfricanAmerican
9.865200E-01
Normal-vs-Asian
3.922800E-01
Caucasian-vs-AfricanAmerican
8.104400E-01
Caucasian-vs-Asian
2.595400E-01
AfricanAmerican-vs-Asian
4.470200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.037000E-01
Normal-vs-Female
6.703200E-01
Male-vs-Female
5.805400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.279200E-01
Normal-vs-Age(41-60Yrs)
8.167600E-01
Normal-vs-Age(61-80Yrs)
5.800800E-01
Normal-vs-Age(81-100Yrs)
2.386000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.898200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.743000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.093000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.060000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.885640E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.138000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.037600E-01
Normal-vs-Daily Drinker
2.836600E-01
Normal-vs-Weekly Drinker
5.238000E-01
Normal-vs-Occasional Drinker
8.896600E-01
Normal-vs-Social Drinker
9.019000E-01
Non Drinker-vs-Daily Drinker
2.709000E-01
Non Drinker-vs-Weekly Drinker
8.091200E-01
Non Drinker-vs-Occasional Drinker
1.964550E-01
Non Drinker-vs-Social Drinker
4.560600E-01
Daily Drinker-vs-Weekly Drinker
4.921400E-01
Daily Drinker-vs-Occasional Drinker
2.848300E-02
Daily Drinker-vs-Social Drinker
9.754200E-02
Weekly Drinker-vs-Occasional Drinker
1.923010E-01
Weekly Drinker-vs-Social Drinker
3.931600E-01
Occasional Drinker-vs-Social Drinker
6.531800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.366570E-01
Normal-vs-Grade 2
1.264000E-02
Normal-vs-Grade 3
1.583530E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.403800E-01
Grade 1-vs-Grade 3
1.888000E-01
Grade 1-vs-Grade 4
1.366570E-01
Grade 2-vs-Grade 3
1.621360E-01
Grade 2-vs-Grade 4
1.264000E-02
Grade 3-vs-Grade 4
1.583530E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.048000E-01
Normal-vs-NonDiabetic
6.873000E-01
Diabetic-vs-NonDiabetic
3.130800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.461600E-01
Normal-vs-NoPancreatitis
6.817400E-01
Pancreatitis-vs-NoPancreatitis
1.132980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.173600E-01
Normal-vs-N1
8.550000E-01
N0-vs-N1
9.460100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.022200E-01
Normal-vs-TP53-NonMutant
6.515800E-01
TP53-Mutant-vs-TP53-NonMutant
2.855800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
